Ultrahuman announced today that it raised $35 million in an equity and debt investment round.
Blume Ventures, Steadview Capital, Nexus Venture Partners, Alpha Wave and Zomato founder Deepinder Goyal participated in the round. Ultrahuman plans to use the funds to build toward further manufacturing capacity and deeper research in the health tracking space.
Ultrahuman develops a smart ring called Ring Air, plus a continuous glucose monitor (CGM) wearable called M1 Live. It also offers a home health device called Ultrahuman Home and a preventive blood testing product called Blood Vision. The company’s platform integrates glucose, sleep, movement, blood markers and HRV for a comprehensive approach to health monitoring.
“This funding round marks a pivotal step forward in our journey to dominate the smart rings space, bringing us closer to our goal of being the market leader” said Mohit Kumar, co-founder of Ultrahuman. “The future of health is integrated, and at Ultrahuman, we’re making that future a reality today by seamlessly combining various health data streams to empower preventative health and wellness.”
The company recently added to its manufacturing capacity with capabilities to support $200 million in annual revenue. Ultrahuman says this signifies its readiness for the next phase of growth.
It also recently completed a clinical trial of 105 participants aimed at validating the metabolic score generated on its platform.
“Our long-term investment in R&D and intellectual property is a cornerstone of our strategy, ensuring that our products not only meet but exceed the highest standards of efficacy and reliability,” Kumar said.